Article

Clinical trials registered in clinical trial registry of India: A survey

Manonmani Alvin Jose1★★ Corresponding author

CORRESPONDENCE

Manonmani Alvin Jose

Pharmjose@gmail.com

Volume 2, Issue 4 · pp. 289–290 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.85952

View on JPP original site ↗

ABSTRACT

As this is just the initiation of accumulating data related to clinical trials taking place in India, exploration of this data may give some insight of the situation and some suggestions for improvement like in a survey of clinical trial registries of western countries it was observed that few ethical aspects like assent from minors and post-trial obligations were not reported adequately.[4] Post-trial obligations describe a duty by research sponsors to provide a successfully tested drug to research participants who took part in the relevant clinical trials after the trial has been conducted. The strong need for this was felt to avoid exploitation of participants and to increase trust development in researcher participant relationship. It has been realized that “informed consent” has only limited direct application in pediatrics. Only patients who have appropriate decisional capacity and legal empowerment can give their informed consent to medical care. In all other situations, parents or other surrogates provide informed permission for diagnosis and treatment of children with the assent of child whenever appropriate. Hence, this study was planned with the objective of exploration of clinical trial registry of India for reporting of various parameters such as methodological, ethical considerations, and disease burden to get insight of the present situation.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Jose, M. A. (2011). Clinical trials registered in clinical trial registry of India: A survey. Journal of Pharmacology and Pharmacotherapeutics, 2(4), 289–290. https://doi.org/10.4103/0976-500X.85952